Status:
UNKNOWN
PRG Combined With Autologous BMMSCs for Treatment of Diabetic Foot Ulcer
Lead Sponsor:
Third Military Medical University
Conditions:
Diabetic Foot Ulcer
Eligibility:
All Genders
20-70 years
Phase:
EARLY_PHASE1
Brief Summary
To investigate the treatment effect between Traditional treatment and transplantation of autologous PRG combined with autologous BMMSCs for treatment of diabetic foot ulcer.
Detailed Description
60 diabetic foot ulcer in our hospital will divide into 3 groups: group A (20 diabetic foot ulcer who give Traditional treatment), group B (20 diabetic foot ulcer who give Traditional treatment and tr...
Eligibility Criteria
Inclusion
- Diabetic foot according to The Wagner is 2-3 graded;
Exclusion
- Type 1 diabetes mellitus,presence of autoimmune diabetes;
- Gestational diabetes;
- Patients with heart, liver, or renal function impairment;presence of severe infections or cerebrovascular disease.
Key Trial Info
Start Date :
August 30 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2020
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03248466
Start Date
August 30 2017
End Date
July 1 2020
Last Update
August 14 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Southwest Hospital of the Third Military Medical University
Chongqing, Chongqing Municipality, China, +86
2
Endocrine Department, the First Affiliated Hospital of the Third Military Medical University
Chongqing, Chongqing Municipality, China, 400038